Literature DB >> 31140550

Mantle Cell Lymphoma With Mantle Zone Growth Pattern.

Ji Yuan1, Shaoying Li2, Xin Liu3, Ruijun Jeanna Su4, Mingyi Chen5, Xiaojun Wu6, Gang Zheng6, Lynette M Smith7, Lifu Wang2,8, Yanxia Li9, Cynthia Liu10, Jiehao Zhou11, Qi Shen12, Linsheng Zhang13, Endi Wang3, Mina L Xu14, Zenggang Pan14.   

Abstract

OBJECTIVES: To characterize the clinical and pathologic features of mantle cell lymphoma with mantle zone growth pattern (MCL-MZGP).
METHODS: The clinicopathologic data from 35 cases of MCL-MZGP obtained in 12 centers were analyzed.
RESULTS: The patients with MCL-MZGP typically sought treatment at high clinical stages (81%). Intriguingly, 40% (14/35) of cases were incidentally noted. The lymph nodes with MCL-MZGP showed preserved architecture and expanded mantles containing lymphoma cells with classic or small cell cytology. MCL-MZGP was positive for BCL2 (96%, bright), CD5 (82%, moderate), cyclin D1 (100%), and SOX11 (89%). Clinically, our study revealed no significant difference in the overall survival between patients managed with observation alone and those who received chemotherapy.
CONCLUSIONS: MCL-MZGP was often incidentally identified and resembled reactive mantles. Therefore, recognition of this unusual morphology emphasizes the utility of cyclin D1 immunostain in the cases with suspicious morphology. However, the clinical significance of these findings is still unclear. © American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cyclin D1; Mantle cell lymphoma; Mantle zone growth pattern; SOX11

Year:  2019        PMID: 31140550     DOI: 10.1093/ajcp/aqz043

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  1 in total

1.  Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like features.

Authors:  Kazuto Togitani; Mitsuko Iguchi; Tadashi Asagiri; Fumiya Ogasawara; Ichiro Murakami; Kensuke Kojima
Journal:  J Clin Exp Hematop       Date:  2021-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.